Trials / Completed
CompletedNCT01125813
Efficacy and Safety Study of Human-cl rhFVIII in PTPs With Severe Hemophilia A
Clinical Study to Investigate the Efficacy, Safety, and Immunogenicity of Human-cl rhFVIII in Previously Treated Patients With Severe Hemophilia A
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Octapharma · Industry
- Sex
- Male
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
This study will determine the efficacy of human-cl rhFVIII in previously treated patients with severe hemophilia A during prophylactic treatment, treatment of bleeding episodes and in surgical prophylaxis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | recombinant Factor VIII | intravenous infusion of factor FVIII every other day. |
Timeline
- Start date
- 2010-06-01
- Primary completion
- 2012-01-01
- Completion
- 2012-01-01
- First posted
- 2010-05-18
- Last updated
- 2017-09-11
- Results posted
- 2013-04-22
Locations
11 sites across 4 countries: Austria, Bulgaria, Germany, United Kingdom
Source: ClinicalTrials.gov record NCT01125813. Inclusion in this directory is not an endorsement.